Vijaya Diagnostic Centre Limited
NSE: VIJAYA BSE: VIJAYA
Prev Close
958.7
Open Price
968
Volume
36,156
Today Low / High
945.5 / 990
52 WK Low / High
740 / 1192
Range
911 - 1,007
Prev Close
937.25
Open Price
957.2
Volume
3,098
Today Low / High
946 / 989
52 WK Low / High
800 / 1191.05
Range
932 - 1,030
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 958.7 (target range: 911 - 1,007), reflecting a change of 1.1368683772162E-13 (1.185843722975E-14%). On the BSE, it is listed at 981.25 (target range: 932 - 1,030), showing a change of 44 (4.69459%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
Vijaya Diagnostic Centre Limited Graph
Vijaya Diagnostic Centre Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Vijaya Diagnostic Centre Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 958.70, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 981.25 | 991.06 | 891.96 - 1,090.17 |
| 1,000.88 | 800.70 - 1,201.05 | ||
| 1,010.69 | 707.48 - 1,313.89 | ||
| Bearish Scenario | 981.25 | 971.44 | 874.29 - 1,068.58 |
| 961.63 | 769.30 - 1,153.95 | ||
| 951.81 | 666.27 - 1,237.36 |
Overview of Vijaya Diagnostic Centre Limited
ISIN
INE043W01024
Industry
Medical - Diagnostics & Research
Vol.Avg
259,203
Market Cap
98,482,399,978
Last Dividend
2
Official Website
IPO Date
2021-09-14
DCF Diff
-1,438.50
DCF
2,397
Financial Ratios Every Investor Needs
Stock Dividend of VIJAYA
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-08-29 | August 29, 25 | 2 | 2 | 2025-08-29 | 2025-10-05 | |
| 2024-08-30 | August 30, 24 | 1 | 1 | 2024-08-30 | 2024-10-06 | |
| 2023-09-13 | September 13, 23 | 1 | 1 | 2023-09-13 | 2023-10-20 | |
| 2022-09-20 | September 20, 22 | 1 | 1 | 2022-09-21 | 2022-10-27 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 681.39 Cr | 84.76 Cr | 596.63 Cr | 0.8756 | 0.00 Cr | 113.25 Cr | 484.47 Cr | 143.08 Cr | 13.95 | 273.22 Cr | 0.2100 |
| 2024-03-31 | 547.81 Cr | 86.37 Cr | 461.43 Cr | 0.8423 | 0.00 Cr | 91.18 Cr | 362.85 Cr | 118.83 Cr | 11.62 | 239.07 Cr | 0.2169 |
| 2023-03-31 | 459.22 Cr | 234.19 Cr | 225.03 Cr | 0.4900 | 0.00 Cr | 78.93 Cr | 122.66 Cr | 84.63 Cr | 8.29 | 195.66 Cr | 0.1843 |
| 2022-03-31 | 462.11 Cr | 71.50 Cr | 390.61 Cr | 0.8453 | 0.00 Cr | 62.29 Cr | 152.80 Cr | 109.68 Cr | 10.76 | 216.02 Cr | 0.2373 |
| 2021-03-31 | 376.45 Cr | 57.10 Cr | 319.36 Cr | 0.8483 | 0.00 Cr | 48.59 Cr | 117.51 Cr | 84.48 Cr | 8.28 | 177.29 Cr | 0.2244 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 48.88 Cr | 1,273.62 Cr | 474.47 Cr | 795.7140 Cr | 319.58 Cr | 270.70 Cr | 4.93 Cr | 793.97 Cr | 0.79 Cr | 0.30 Cr | 0.04 Cr | 162.6140 Cr |
| 2024-03-31 | 22.25 Cr | 982.75 Cr | 322.84 Cr | 657.1934 Cr | 259.18 Cr | 236.94 Cr | 5.18 Cr | 610.38 Cr | 0.77 Cr | 0.34 Cr | 11.34 Cr | 72.8659 Cr |
| 2023-03-31 | 24.18 Cr | 853.41 Cr | 306.78 Cr | 544.7294 Cr | 247.56 Cr | 223.38 Cr | 2.05 Cr | 543.48 Cr | 0.68 Cr | 0.46 Cr | 0.56 Cr | 66.1687 Cr |
| 2022-03-31 | 11.05 Cr | 713.46 Cr | 243.92 Cr | 468.2193 Cr | 183.46 Cr | 172.41 Cr | 4.28 Cr | 418.02 Cr | 27.68 Cr | 0.12 Cr | 0.18 Cr | 66.1238 Cr |
| 2021-03-31 | 6.69 Cr | 540.94 Cr | 181.71 Cr | 359.0060 Cr | 141.05 Cr | 134.36 Cr | 2.64 Cr | 273.42 Cr | 0.99 Cr | 0.00 Cr | -206.99 Cr | 44.2888 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 224.4725 Cr | -181.8713 Cr | -52.0478 Cr | 128.9200 Cr | -9.4466 Cr | 12.8011 Cr | -95.5525 Cr | 143.0753 Cr | -21.9663 Cr | -10.2623 Cr | 0.2500 Cr |
| 2024-03-31 | 183.3009 Cr | -142.3073 Cr | -44.5495 Cr | 95.3370 Cr | -1.9292 Cr | 22.2477 Cr | -87.9639 Cr | 118.8253 Cr | -37.3733 Cr | -10.2267 Cr | -2.3042 Cr |
| 2023-03-31 | 164.6117 Cr | -109.5724 Cr | -41.9123 Cr | 39.7691 Cr | 13.1270 Cr | 24.1769 Cr | -124.8426 Cr | 113.5100 Cr | -0.6346 Cr | -10.2111 Cr | 2.2282 Cr |
| 2022-03-31 | 157.9987 Cr | -123.0623 Cr | -30.5721 Cr | 35.6502 Cr | 4.3643 Cr | 11.0499 Cr | -122.3485 Cr | 147.3843 Cr | -3.8368 Cr | 0.0000 Cr | -1.6324 Cr |
| 2021-03-31 | 129.6430 Cr | -129.7570 Cr | -48.7690 Cr | 97.5070 Cr | -48.8830 Cr | 6.6860 Cr | -32.1360 Cr | 112.1240 Cr | -28.3677 Cr | 0.0000 Cr | 0.1290 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 201.56 Cr | 78.85 Cr | 122.72 Cr | 0.6088 | 59.56 Cr | 43.28 Cr | 4.21 | 88.08 Cr | 0.2147 |
| 2025-06-30 | 188.05 Cr | 21.41 Cr | 166.64 Cr | 0.8861 | 52.64 Cr | 38.34 Cr | 3.76 | 80.58 Cr | 0.2039 |
| 2025-03-31 | 173.24 Cr | 22.17 Cr | 151.08 Cr | 0.8721 | 122.67 Cr | 34.64 Cr | 3.38 | 67.69 Cr | 0.1999 |
| 2024-12-31 | 168.98 Cr | 20.85 Cr | 148.13 Cr | 0.8766 | 48.83 Cr | 35.16 Cr | 3.42 | 71.83 Cr | 0.2080 |
| 2024-09-30 | 182.95 Cr | 22.99 Cr | 159.96 Cr | 0.8743 | 59.15 Cr | 41.94 Cr | 4.09 | 80.49 Cr | 0.2292 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 29.28 Cr | 228.68 Cr | 257.96 Cr | 11.95 Cr | 3.58 Cr | 320.44 Cr | 888.67 Cr | 1,390.70 Cr | 525.63 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 233.48 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -799.14 Cr |
| 2025-03-31 | 48.88 Cr | 184.60 Cr | 233.48 Cr | 14.76 Cr | 4.93 Cr | 307.21 Cr | 793.97 Cr | 1,273.62 Cr | 474.47 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 211.37 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -727.95 Cr |
| 2024-09-30 | 14.67 Cr | 235.63 Cr | 250.30 Cr | 12.83 Cr | 6.64 Cr | 274.61 Cr | 681.12 Cr | 1,125.30 Cr | 397.35 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 38.34 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 34.64 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 35.16 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 41.94 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 31.35 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Diagnostics & Research
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Dr. Lal PathLabs Limited | LALPATHLAB | ₹1,425.00 | ₹237,937,200,450.00 | ₹135,081.00 |
| Sai Life Sciences Ltd. | SAILIFE | ₹839.35 | ₹177,296,613,948.00 | ₹168,172.00 |
| Vijaya Diagnostic Centre Limited | VIJAYA | ₹958.70 | ₹98,482,399,978.00 | ₹36,156.00 |
| Metropolis Healthcare Limited | METROPOLIS | ₹1,873.00 | ₹97,081,148,700.00 | ₹43,516.00 |
Key Executives
Gender: Not Specified
Year Born: 1948
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born: 1975
Gender: female
Year Born: 1981
FAQs about Vijaya Diagnostic Centre Limited
The CEO is Sura Suprita Reddy.
The current price is ₹958.70.
The range is ₹740-1192.
The market capitalization is ₹9,848.24 crores.
The dividend yield is 0.21%.
The P/E ratio is 65.04.
The company operates in the Healthcare sector.
Overview of Vijaya Diagnostic Centre Limited (ISIN: INE043W01024) is a leading Medical - Diagnostics & Research in India. With a market capitalization of ₹9,848.24 crores and an average daily volume of 259,203 shares, it operates in the Medical - Diagnostics & Research. The company last declared a dividend of ₹2.